Rondol is proud to announce its cooperation with Extrupharm in Southbridge, MA, USA.

08 Apr 2019

As Hot Melt Extrusion (HME) becomes more and more established in the pharmaceutical industry it also becomes ever more important to improve existing formulations and manufacturing processes. 

David White founded Extrupharm in order to help companies and research organisations to fully utilize their potential in extrusion and offers a complete consulting service from proof of principle to the custom design of extrusion lines.

David White says: « Partnering with Rondol is key for Extrupharm to offer our customers state of the art HME equipment for developing their extrusion processes »

For Rondol to reach an agreement with Extrupharm is an important step in order to get closer to our US based clients. 

Bill Darling, Chairman Woodstock Corporation says: « 16 months after investing in Rondol, we are happy to witness the start of this cooperation with David who has such a strong reputation as an HME expert in the US market »

As part of this cooperation a Rondol All in One Vertical extruder will be installed at Extrupharm's site in Southbridge, MA, USA and will be fully operational and available for trials and projects by the end of May.

Victoire de Margerie, Chairman Rondol Industrie says: « This agreement with Extrupharm is a new step on accomplishing our dream to use HME technology for reducing the cost and complexity of medical care while enhancing treatment efficiency and confort for patients »

The Rondol Vertical that offers a significant reduction in the footprint of the equipment compared to a traditional horizontal design has been prominently featured on Rondol's website before